Is There Indication for the Use of Biological Mesh in Cancer Patients?
abdominal wall
biological mesh
mesh
oncological patients
ventral hernia
ventral hernia repair
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
13 Oct 2022
13 Oct 2022
Historique:
received:
02
09
2022
revised:
07
10
2022
accepted:
11
10
2022
entrez:
27
10
2022
pubmed:
28
10
2022
medline:
28
10
2022
Statut:
epublish
Résumé
Up to 28% of all patients who undergo open surgery will develop a ventral hernia (VH) in the post-operative period. VH surgery is a debated topic in the literature, especially in oncological patients due to complex management. We searched in the surgical database of the Hepatobiliary Unit of the National Cancer Institute of Naples "G. Pascale Foundation" for all patients who underwent abdominal surgery for malignancy from January 2010 to December 2018. Our surgical approach and our choice of mesh for VH repair was planned case-by-case. We selected 57 patients that fulfilled our inclusion criteria, and we divided them into two groups: biological versus synthetic prosthesis. Anterior component separation was used in 31 patients (54.4%) vs. bridging procedure in 26 (45.6%). In 41 cases (71.9%), we used a biological mesh while a synthetic one was adopted in the remaining patients. Of our patients, 57% were male (33 male vs. 24 female) with a median age of 65 and a mean BMI of 30.8. We collected ventral hernia defects from 35 cm
Identifiants
pubmed: 36294356
pii: jcm11206035
doi: 10.3390/jcm11206035
pmc: PMC9605183
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
BMC Surg. 2019 Apr 24;18(Suppl 1):125
pubmed: 31074399
Surgery. 2020 Sep;168(3):509-517
pubmed: 32439207
Surg Clin North Am. 2018 Jun;98(3):431-440
pubmed: 29754613
Br J Surg. 2020 Feb;107(3):209-217
pubmed: 31875954
Surg Endosc. 2017 May;31(5):2149-2154
pubmed: 27604372
Surg Infect (Larchmt). 2016 Feb;17(1):17-26
pubmed: 26375422
Biology (Basel). 2021 Mar 11;10(3):
pubmed: 33799618
Hernia. 2012 Apr;16(2):179-83
pubmed: 21904861
World J Surg. 2017 Oct;41(10):2488-2491
pubmed: 28462438
Am Surg. 2020 Sep;86(9):1159-1162
pubmed: 32853025
Surg Endosc. 2022 May;36(5):3374-3381
pubmed: 34462867
Cancer Control. 2021 Jan-Dec;28:1073274820985786
pubmed: 33567876
Ann Plast Surg. 2019 Apr;82(4):435-440
pubmed: 30562207
Colorectal Dis. 2012 Dec;14 Suppl 3:7-11
pubmed: 23136818
J Am Coll Surg. 2013 Dec;217(6):999-1009
pubmed: 24083910
Hernia. 2019 Feb;23(1):81-90
pubmed: 30564978
Ann Surg. 2021 Jan 1;273(1):57-65
pubmed: 33332873
Surgery. 2017 Feb;161(2):499-508
pubmed: 27810091
World J Surg Oncol. 2016 Oct 6;14(1):257
pubmed: 27716306
J Gynecol Oncol. 2009 Dec;20(4):246-50
pubmed: 20041103
J Clin Med. 2021 Oct 27;10(21):
pubmed: 34768516
Hernia. 2021 Feb;25(1):107-114
pubmed: 32719913
World J Surg. 2011 Feb;35(2):297-301
pubmed: 21136057
Hernia. 2020 Apr;24(2):265-272
pubmed: 31127401
Ann Surg Oncol. 2016 Dec;23(Suppl 5):764-771
pubmed: 27743227
J Am Coll Surg. 2017 Mar;224(3):341-350
pubmed: 27993696
J Am Coll Surg. 2022 Jun 1;234(6):1165-1166
pubmed: 35703815
BMC Surg. 2019 Apr 24;18(Suppl 1):123
pubmed: 31074403
Tech Coloproctol. 2018 Aug;22(8):623-625
pubmed: 30094713
Tech Coloproctol. 2019 Apr;23(4):379-383
pubmed: 30989414
J Surg Oncol. 2015 May;111(6):725-8
pubmed: 25580588
Surg Endosc. 2022 Jun 21;:
pubmed: 35729405